top of page
About Cellmover

Cellmover is a pre-clinical stage immunotherapy company committed to optimizing the tools of the immune system, with a vision to broaden the application of immunotherapies for various cancers.

cellmover
The technology

Cellmover has developed a library of nanobodies and peptides directed at intracellular targets in T cells and NK cells.

 

By targeting these proteins, the nanobodies and peptides mediate increased survival and persistence of immune cells within the tumor microenvironment.

Miriam Aarsund Larsen
With support from
Eurostars.jpg
Members of
Aleap.png
Cellmover.png

Cellmover AS

​

ShareLab

Gaustadalléen 21

0349, Oslo

Norway

Contact

​

info@cellmover.com

​

Policy​

​

​

Follow us​

  • LinkedIn
  • X
  • Facebook

©2025 Cellmover AS. All rights reserved.

bottom of page